University Hospital Bern, Department of Ophthalmology
Bern, 3010, Switzerland
NCT Number: NCT04010383
It is hypothesized that performing VF measurements with a Virtual Reality headset using similar testing strategies as implemented in conventional perimeters, allow for a non-inferior quality in VF acquisitions. The results of this study will show if valid measurements of such devices in human subjects can be obtained.
The primary endpoint of this study is the non-inferiority estimation quality of participant's mean defect (MD) measured in decibel (dB) between the head-mounted display and an OCTOPUS perimeter using the dynamic strategy (DS) for participants with normal or glaucomatous visual field. The MD is a clinical measure for the average loss of visual function calculated from the visual field of a participant.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Observational
Bern, 3010, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Written informed consent
Inclusion criteria
for normal visual field subjects:
Inclusion criteria
for glaucomatous subjects:
Exclusion criteria
Both groups will be examined with a standard automated perimeter as well as with the virtual reality perimeter.
Time frame: 2 weeks
The primary endpoint of this study is the non-inferiority estimation quality of participant's mean defect (MD) measured in decibel (dB) between the head-mounted display and an OCTOPUS perimeter using the dynamic strategy (DS) for participants with normal or glaucomatous visual field. The MD is a clinical measure for the average loss of visual function calculated from the visual field of a participant.
Insel Gruppe AG, University Hospital Bern
Other
Non-inferiority Study for Visual Field Measurements Using a Virtual Reality Device on Participants With Normal and Glaucomatous Visual Fields
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02162381
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Petah Tikva, Israel
View Trial DetailsNCT07327242
Eye Diseases, Eye Disorders
Palo Alto, California, United States
View Trial Details